• No results found

Platelet Inhibition and

N/A
N/A
Protected

Academic year: 2021

Share "Platelet Inhibition and "

Copied!
1
0
0

Loading.... (view fulltext now)

Full text

(1)

Platelet Inhibition and

Bleeding Complications in Cardiac Surgery Patients

Clinical and experimental studies

Emma C. Hansson

ISBN 978-91-628-9892-2 (PRINT) ISBN 978-91-628-9893-9 (PDF) http://hdl.handle.net/2077/43458 Printed by Ineko AB, Gothenburg

Platelet Inhibition and Bleeding Complications in Cardiac Surgery Patients | Emma C. Hansson

SAHLGRENSKA ACADEMY INSTITUTE OF MEDICINE

DOCTORAL THESIS

SAHLGRENSKA ACADEMY

2016

101326_GU_Emma_Hansson_omslag.indd 1 2016-08-22 14:15:21

References

Related documents

The aims were to determine (1) whether thromboelas- tometry analyses can be accelerated, (2) whether routine use of intraoperative thromboe- lastometry reduces

The main findings in this thesis were; IPU concentrates maintained a better platelet function compared to buffy-coat platelet concentrates during storage while apheresis

Results: Platelets in interim platelet unit (IPU) concentrates maintained a lower activation state and better aggregation response to the end of storage compared to

The general aim of this work was to investigate the effect of platelet inhibition on bleeding complications and transfusion requirements in cardiac surgery patients, to examine

BACKGROUND AND OBJECTIVE: Dual antiplatelet therapy (DAPT) with acetylsalicylic acid and a P2Y 12 inhibitor (clopidogrel, ticagrelor, or prasugrel) reduces thrombotic events

[r]

II: Postoperative bleeding volume correlated univariately with preoperative fibrinogen concentration (r = -0.53, p<0.001). Fibrinogen was an independent predictor of

Fibrinogen, platelet and factor XIII supplementation in cardiac surgery | Caroline Shams Hakimi. SAHLGRENSKA ACADEMY INSTITUTE